BeStock  
Stocks › Biotechnology › INSM

Insmed INSM

US equityMarket cap rank #631Biotechnology
$141.33 −$3.13 (-2.17%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $142.81 +1.05%
Open$143.27
Prev close$144.46
Day range$140.99 – $150.00
Volume6.22M
Market cap$31.01B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership101.8%-0.24 pts vs. prior quarter
Institutions holding887-1 vs. prior quarter
Insider trades (recent)11 buys / 37 sellsNet selling
Short interest6.42% of floatDays to cover 3.6 · as of 30 Oct 2026
Short-sale volume share11.5%5-day average of daily volume

Short-sale volume as % of daily volume

5%9%12%15%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$19.46M (15 inflow days, 5 outflow days).

Net flow by order size, last 20 sessions

+$6.6MSuper+$12.8MBig−$20.1MMid−$16.8MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 28.0% of shares outstanding.

Largest holders

  • BlackRock7.25%
  • FMR6.58%
  • Vanguard Capital Management, LLC5.13%
  • Vanguard Portfolio Management, LLC4.80%
  • Capital Research4.26%
  • Baker Bros. Advisors LP4.01%
  • J.P. Morgan Asset Management, Inc.3.35%
  • Darwin Global Management Limited2.93%

By investor type

  • Mutual Fund71.66%
  • Hedge Fund21.67%
  • Public Company2.30%
  • Sovereign Wealth Fund1.60%
  • Private Company1.57%
  • VC/PE Fund1.03%
  • Government Pension Fund0.89%
  • Individual/Insider0.62%

Reported short interest has risen from 4.99% to 6.42% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
AQR Capital Management Hedge Fund 2026/Q4 +4,493,948 2.3%
Vestal Point Capital, LP Hedge Fund 2026/Q4 +2,475,000 1.2%
Castle Hook Partners LP Hedge Fund 2026/Q4 +1,563,717 1.2%
Paradigm Biocapital Advisors LP Hedge Fund 2026/Q4 +1,370,000 1.2%
Deep Track Capital, LP VC/PE Fund 2026/Q4 +1,350,000 0.6%
Capital Research Mutual Fund 2026/Q4 +1,114,509 4.3%
Assenagon Asset Management S.A. Mutual Fund 2026/Q4 +1,048,518 0.6%
Royal Bank of Canada Public Company 2026/Q4 +1,015,196 0.6%
Polar Capital Holdings Plc Mutual Fund 2026/Q4 +862,891 0.8%
Holocene Advisors, LP Hedge Fund 2026/Q4 +857,408 0.5%
Amundi Asset Management Mutual Fund 2026/Q4 +766,121 0.6%
Orbis Investment Management Limited Mutual Fund 2026/Q4 +657,495 3.1%
Jane Street Group, LLC Private Company 2026/Q4 +626,964 0.4%
Renaissance Technologies Corp. Hedge Fund 2026/Q4 +553,987 0.3%
Pictet Asset Management Limited Mutual Fund 2026/Q4 +537,188 0.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
29 Oct 2026 Patrick Kane Initial Statement of Beneficial +0 – 7,504
18 Oct 2026 Paul Hudson Independent Director Other Acquisition +6,139 – 6,139
18 Oct 2026 Utpal Koppikar Independent Director Other Acquisition +6,139 – 6,139
8 Sep 2026 David Brennan Lead Independent Director Open Market Disposition -25,000 $124.00 95,933
16 Aug 2026 Melvin Sharoky Independent Director Open Market Disposition -5,000 $127.53 264,596
9 Aug 2026 Roger Adsett Chief Operating Officer Derivative Exercise and Sale -239,850 $133.27 59,362
5 Aug 2026 Martina Flammer Chief Medical Officer Derivative Exercise and Sale -27,173 $129.40 10,880
22 Jul 2026 William Lewis Chairperson & CEO Derivative Exercise and Sale -10,700 $106.43 368,795
8 Jul 2026 William Lewis Chairperson & CEO Derivative Exercise and Sale -10,699 $118.52 368,795
5 Jul 2026 Martina Flammer Chief Medical Officer Derivative Exercise and Sale -12,302 $110.60 60,486
24 Jun 2026 William Lewis Chairperson & CEO Derivative Exercise and Sale -21,398 $106.27 368,654
22 Jun 2026 Samuele Butera Senior VP & GM of Global Respiratory Other Acquisition +7,342 – 7,342
22 Jun 2026 Samuele Butera Senior VP & GM of Global Respiratory Other Derivative Acquisition +12,570 $102.15 12,570
21 Jun 2026 Michael Smith Chief Legal Officer Automatic Disposition -1,806 $95.82 37,648
7 Jun 2026 William Lewis Chairperson & CEO Automatic Disposition -6,515 $94.03 492,841
4 Jun 2026 Martina Flammer Chief Medical Officer Open Market Disposition -4,424 $103.78 19,631
2 Jun 2026 William Lewis Chairperson & CEO Open Market Disposition -7,605 $102.27 499,356
2 Jun 2026 Roger Adsett Chief Operating Officer Open Market Disposition -2,370 $102.27 59,221
2 Jun 2026 Sara Bonstein Former Chief Financial Officer Open Market Disposition -2,404 $102.27 23,237
2 Jun 2026 Michael Smith Chief Legal Officer Open Market Disposition -2,159 $102.27 39,454

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 14,080,405 6.4% 3.6
15 Oct 2026 13,477,593 6.2% 4.1
30 Sep 2026 13,800,693 6.3% 6.5
15 Sep 2026 10,802,070 4.9% 5.3
31 Aug 2026 11,440,176 5.2% 6.9
14 Aug 2026 10,892,278 5.0% 2.7

Discussion

No comments yet — be the first to weigh in on INSM.

Sign in to join the discussion.

Scroll to Top